Please login to the form below
cardiology
This page shows the latest cardiology news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca to acquire Alexion for $39bn
metabolic disorders, cardiology, ophthalmology and acute care.
Latest news
-
PMEA 2020: continuing to recognise excellence in improving patient outcomes
Winner: Challenging the Traditional: Shaping the Future of Cardiology by Edwards Lifesciences with support from VCCP Health.
-
Praising the medical team for an excellent launch
This may vary depending on the company culture and processes, disease area/speciality and launch archetype – a rare disease medical organisation will look very different from one in vaccines or cardiology.
-
What makes a great launch leader and launch team?
Whether it was receiving a regulatory ‘no’ after a year of planning a respiratory launch in the UK or a European- wide successful cardiology launch that exceeded everyone’s expectations.
-
AZ’s Farxiga cuts risk of death in chronic kidney disease
Detailed results revealed at the European Society of Cardiology virtual congress. ... AstraZeneca (AZ) has revealed some impressive results from a phase 3 study of its heart failure drug Farxiga in chronic kidney disease (CKD) at the European Society of
-
Merck, Bayer flesh out vericiguat heart failure data at ACC
The data were presented at the American College of Cardiology (ACC) conference – taking place for the first remotely because of the coronavirus pandemic – and also published in the New England Journal
More from news
Approximately 8 fully matching, plus 156 partially matching documents found.
Latest Intelligence
-
Putting theory into practice
In a medical context, for example, they see adoption as occurring in the clinical unit, such as an operating department or a cardiology lab.
-
Treatment and prevention of cardiovascular disease
with omega-3 CA’, as reported by the American College of Cardiology on 15 November 2020.
-
How can pharma build bridges with HCPs online?
The programme was targeted to HCPs in haematology, cardiology, geriatrics and elderly care audiences in ten key regions.
-
Here’s to all the bright sparks
The next year, in 1950, John Hopps turned the world of cardiology upside down when he invented the pacemaker.
-
The hitchhiker’s guide to the millennial healthcare professional
and social channels to direct them to robust clinical information before eventually starting up his own repository for cardiology information.
More from intelligence
Approximately 1 fully matching, plus 16 partially matching documents found.
Latest appointments
-
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare
At BMS, he worked as senior regional access manager and led new customer-focused initiatives in cardiology and oncology.
-
New faces at W2O, 90TEN and Porterhouse
During her career, Baccari has lead high-profile global initiatives across various therapy areas including neurology, oncology and cardiology.
-
emotive bolsters client services team
During her six years at Chameleon, she was responsible for medical communications acitivites in various therapy areas including diabetes, cardiology, immunology, gastroenterology and rare diseases.
-
Axon bolsters team with new PR Director hire
During her career, Smiddy has led local, regional and international programmes to support pharmaceutical products in numerous therapeutic fields including cardiology, immunology, CNS and oncology.
-
Former Novartis vaccines CMO joins Arterial
board. Dr Weissback brings over 25 years of life science industry experience to the post - with particular expertise in cardiology, infectious diseases and oncology - and is currently chief operating officer at
More from appointments
Approximately 0 fully matching, plus 20 partially matching documents found.
Latest from PMHub
-
The Week After
The Week After looks at the risks associated with atrial fibrillation - the teaser looks to capture the attention of cardiology to step in and act.
-
If our patients are diverse, why are clinical trials so white?
Worryingly, this lack of diversity in clinical trials is common not only in dermatology, but across healthcare as a whole, ranging from oncology to cardiology, especially when pertaining to marginalised populations.
-
My Journey into Medical Communications #LucidLife
A standout moment for me was producing the materials needed for ESC, the world's largest cardiology congress, which took place in Paris this year.
-
Lucid Group adds more magic to the mix with four new hires
Megan has experience in cardiology, vaccines, dermatology and oncology. With a BSc and MSc in Psychology, she is passionate about the use of behaviour change to improve patient outcomes.
-
Wilmington Healthcare appoints new consultants
He has joined Wilmington Healthcare from Bristol-Myers Squibb, where he was Senior Regional Access Manager and led new customer- focused initiatives for the company in cardiology and oncology.
More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
- J&J looks ahead at potential flu therapy after approval of its COVID-19 vaccine
- AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER
- UK study finds Pfizer/BioNTech, AZ/Oxford vaccines reduce severe COVID-19 in older people
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Lilly’s RET inhibitor Retevmo shows early promise in new cancer types
- Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
- FDA approves new self-injection administration for Xolair
- Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients
- Scientific meetings: leveraging on-site, virtual, on-demand and enduring materials
- Waterland-backed imc group progresses ambitious growth strategy with the addition of Indigo Medical
PMHub
fox&cat
up to your ears in it? some pressure is helpful but too much of the wrong sort quickly takes its...
Latest intelligence
- Want to give perfect client service? Tough luck, you’re human
- In this article an ex-client of mine, Liz Skrbkova, and I explore the (unhelpful) pressures of trying to perfect the client-agency relationship...
- WHITE PAPER: Why do men die younger?
- It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
Quick links
Infographics
